{"id":49969,"date":"2022-10-24T12:01:47","date_gmt":"2022-10-24T10:01:47","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-otc-topical-drugs-market-report-2022-increasing-number-of-skin-diseases-and-the-prevalence-of-musculoskeletal-pain-driving-sector-researchandmarkets-com\/"},"modified":"2022-10-24T12:01:47","modified_gmt":"2022-10-24T10:01:47","slug":"global-otc-topical-drugs-market-report-2022-increasing-number-of-skin-diseases-and-the-prevalence-of-musculoskeletal-pain-driving-sector-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-otc-topical-drugs-market-report-2022-increasing-number-of-skin-diseases-and-the-prevalence-of-musculoskeletal-pain-driving-sector-researchandmarkets-com\/","title":{"rendered":"Global OTC Topical Drugs Market Report 2022: Increasing Number of Skin Diseases and the Prevalence of Musculoskeletal Pain Driving Sector – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Global OTC Topical Drugs Market (2022 Edition) – Analysis By Drug Class, Indication, End User, Formulation, Distribution Channel, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2023-2028)”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nAccording to a research report published in August 2022, the Global OTC Topical drugs market was valued at USD 44.6 billion in the year 2021. The global OTC Topical Drugs Market is driven by an increasing number of skin diseases and the prevalence of musculoskeletal pain across the globe.\n<\/p>\n

\nIn addition, an increase in health expenditure, a growing population, an increasingly ageing population, and increasing disposable income in several developing countries are the factors anticipated to propel the growth of the global OTC topical drugs market.\n<\/p>\n

\nAdditionally, life expectancy has increased due to various health care reforms in major economies such as the U.S., Japan, and China. This is likely to drive demand for many OTC topical drugs for optic, ophthalmic, skin diseases and chronic pain conditions which are highly prevalent in the ageing population. Asia-Pacific region is anticipated to grow at the fastest rate during the forecast period owing to the rising investments in the healthcare industry by private companies in developing countries such as China and India.\n<\/p>\n

\nThe leading pharmaceutical companies in the OTC Topical Drugs market are focusing on introducing and receiving medical approval for famous prescription topical drugs under the OTC category with the same dosage form, population, and route of administration. This strategy reduces crowding in the prescription portfolio of the company and brings new products to the OTC category, as well as extending the market life of mature prescription drugs. In the last three years, around eight prescription drugs have been approved for OTC by the U.S. FDA including the latest approval of Nasonex 24HR Allergy in March 2022.\n<\/p>\n

\nScope of the Report:<\/strong>\n<\/p>\n